Shioi Junichi, Georgakopoulos Anastasios, Mehta Pankaj, Kouchi Zen, Litterst Claudia M, Baki Lia, Robakis Nikolaos K
Department of Psychiatry, Mount Sinai School of Medicine, New York University, New York, NY 10029, USA.
J Neurochem. 2007 May;101(3):674-81. doi: 10.1111/j.1471-4159.2006.04391.x. Epub 2007 Jan 24.
Strong support for a primary causative role of the Abeta peptides in the development of Alzheimer's disease (AD) neurodegeneration derives from reports that presenilin familial AD (FAD) mutants alter amyloid precursor protein processing, thus increasing production of neurotoxic Abeta 1-42 (Abeta 42). This effect of FAD mutants is also reflected in an increased ratio of peptides Abeta 42 over Abeta 1-40 (Abeta 40). In the present study, we show that several presenilin 1 FAD mutants failed to increase production of Abeta 42 or the Abeta 42/40 ratio. Our data suggest that the mechanism by which FAD mutations promote neurodegeneration and AD may be independent of their effects on Abeta production.
关于β淀粉样肽(Abeta)在阿尔茨海默病(AD)神经退行性变发展过程中起主要致病作用的有力证据来自以下报道:早老素家族性AD(FAD)突变体改变淀粉样前体蛋白的加工过程,从而增加神经毒性Abeta 1-42(Abeta 42)的产生。FAD突变体的这种作用还反映在Abeta 42与Abeta 1-40(Abeta 40)的肽比例增加上。在本研究中,我们发现几种早老素1 FAD突变体未能增加Abeta 42的产生或Abeta 42/40比例。我们的数据表明,FAD突变促进神经退行性变和AD的机制可能与其对Abeta产生的影响无关。